Substance Use Issues: New Insights

Editorial: A New Public Understanding About Addiction
Ilana Crome, MD, FRCPsychKeele University and South Staffordshire and Shropshire Healthcare NHS Foundation Trust, Stafford, ST16 3SR, UK.A. Thomas McLellan, PhD

The Treatment Research Institute, 600 Public Ledger Bld., 150 S. Independence Mall, Philadelphia, PA 19106, USA.


The Recovery Agenda: The Shared Role of Peers and Professionals
William L. White, MA,

Chestnut Health Systems, Punta Gorda, FL, USA.

Arthur C. Evans, Jr., PhD

Philadelphia Department of Behavioral Health and Developmental disAbility Services, Philadelphia, PA, USA.

Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group
A. Thomas McLellan, PhD

The Treatment Research Institute, Philadelphia PA, USA.

Joanna L. Starrels, MD, MS

Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.

Betty Tai, PhD

National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.

Adam J. Gordon, MD, MPH

University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Richard Brown, MD, MPH

University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA.

Udi Ghitza, PhD

National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.

Marc Gourevitch, MD

New York University School of Medicine, Department of Population Health, New York, NY, USA.

Jack Stein, PhD

National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.

Marla Oros, RN, MS

The Mosaic Group, Baltimore MD. USA.

Terry Horton, MD

Christiana Care Health System, Division of Addiction Medicine, Wilmington DE, USA.

Robert Lindblad, MD

The EMMES Corporation, Rockville, MD, USA.

Jennifer McNeely, MD, MS
New York University School of Medicine, Department of Population Health, New York, NY, USA.

Why Changes in Price Matter When Thinking About Marijuana Policy: A Review of the Literature on the Elasticity of Demand
Rosalie Liccardo Pacula, PhD

RAND Corporation, Santa Monica, CA, USA

National Bureau of Economic Research, Cambridge, MA, USA

Russell Lundberg, PhD

National Bureau of Economic Research, Cambridge, MA, USA.

Substance Use and Associated Health Conditions throughout the Lifespan
Marya T. Schulte, PhD

UCLA Integrated Substance Abuse Programs, University of California, Los Angeles, CA, USA.

Yih-Ing Hser, PhD

UCLA Integrated Substance Abuse Programs, University of California, Los Angeles, CA, USA.

Can Neuroscience Improve Addiction Treatment and Policies?
David Nutt, FMedSci

Imperial College London, London, UK.

A. Thomas McLellan, PhD

Treatment Research Institute, Philadelphia, PA, USA.

The Brazilian Drug Policy Situation: The Public Health Approach Based on Research Undertaken in a Developing Country
Marcelo Ribeiro, MSc, PhD

Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Reference Center for Alcohol, Tobacco and other Drugs (CRATOD) – São Paulo State Government, São Paulo, Brazil.
National Institute of Science and Technology for Public Policies in Alcohol and Drug

Luciane Ogata Perrenoud

Federal University of São Paulo (UNIFESP), São Paulo, Brazil.

Sérgio Duailibi, MD, PhD

Federal University of São Paulo (UNIFESP), São Paulo, Brazil.

National Institute of Science and Technology for Public Policies in Alcohol and Drugs (INPAD), Federal University of Sao Paulo (UNIFESP), São Paulo, Brazil.

Lígia Bonacim Duailibi, MSc

Federal University of São Paulo (UNIFESP), São Paulo, Brazil.

Clarice Madruga, MSc, PhD

National Institute of Science and Technology for Public Policies in Alcohol and Drugs (INPAD), Federal University of Sao Paulo (UNIFESP), São Paulo, Brazil.

Ana Cecília Petta Roseli Marques, MD, PhD

National Institute of Science and Technology for Public Policies in Alcohol and Drugs (INPAD), Federal University of Sao Paulo (UNIFESP), São Paulo, Brazil.

Brazilian Association for the Study of Alcohol and Other Drugs (ABEAD), Brazil.

Ronaldo Laranjeira, MD, PhD

Federal University of São Paulo (UNIFESP), São Paulo, Brazil.

National Institute of Science and Technology for Public Policies in Alcohol and Drugs (INPAD),

Special Advisor for Drug Policy (Programa Recomeço), São Paulo State Government, Brazil.

 

Addiction Science: A Rationale and Tools for a Public Health Response to Drug Abuse
Richard A. Rawson, PhD

Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Traci Rieckmann, PhD

Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Oregon Health & Science University, School of Medicine, Department of Public Health, OR, USA.

Steven W. Gust, PhD

National Institute on Drug Abuse, US National Institutes of Health, Bethesda, MD, USA.